Fortrea Holdings reinstated Jason Knoblauch as chief financial officer following a legal dispute with his former employer.

Knoblauch had initially joined the contract-research company in July. He was placed on a paid leave of absence later that month after a Delaware court granted a temporary restraining order preventing him from working in the role after his prior employer filed a lawsuit alleging he violated certain restrictive covenants and retained confidential information.

Knoblauch previously worked at Clario, an endpoint data-solutions provider in the clinical-trials industry, which was acquired by Thermo Fisher Scientific in March.

David Smith, a director on Fortrea's board, had been CFO on an interim basis during Knoblauch's leave.